Results 131 to 140 of about 30,696 (201)

Review Article: Classic Bismuth Quadruple Therapy for Helicobacter pylori Infection—Questions Focused on Clinical Practice

open access: yesAlimentary Pharmacology &Therapeutics, Volume 63, Issue 5, Page 616-636, March 2026.
BQT remains the most effective, safe, and practical regimen for H. pylori eradication, ensuring high cure rates across diverse resistance patterns and clinical settings. ABSTRACT Background Classic bismuth quadruple therapy (BQT)—the combination of a proton pump inhibitor, bismuth, tetracycline, and metronidazole—is a standard regimen for treating ...
Javier P. Gisbert   +2 more
wiley   +1 more source

The dynamic elimination effect of local adjuvant therapy on the periodontal microbiota. [PDF]

open access: yesJ Oral Microbiol
Li X   +10 more
europepmc   +1 more source

Chronic hepatitis in horses with persistent equine hepacivirus infection

open access: yesEquine Veterinary Journal, Volume 58, Issue 2, Page 444-457, March 2026.
Abstract Background Equine hepacivirus (EqHV) is closely related to hepatitis C virus (HCV), which causes persistent infection and chronic hepatitis in people. Information on persistent EqHV infection and hepatitis is limited. Objectives To report 19 cases of chronic hepatitis and persistent EqHV infection.
Mason C. Jager   +13 more
wiley   +1 more source

Lung organoids as a human system for Mycobacteria infection modeling and drug testing

open access: yesThe FEBS Journal, Volume 293, Issue 6, Page 1587-1611, March 2026.
Mycobacterial infections, including tuberculosis (TB) and infections by nontuberculous mycobacteria (NTM), are still public health issues. In 2023, TB caused 1.25 million deaths, while NTM remain a clinical challenge for patients with cystic fibrosis (CF).
Stephen Adonai Leon‐Icaza   +4 more
wiley   +1 more source

Integrating Dermocosmetics Into Acne Care in Latin America

open access: yesJournal of Cosmetic Dermatology, Volume 25, Issue 3, March 2026.
ABSTRACT Background Prescription acne products have proven efficacy and safety, yet management can pose a challenge. This review discusses the benefits of adding dermocosmetics to acne management. Methods We add expert consensus with review of the literature to provide guidance for clinicians managing patients with acne in Latin America.
Patricia Troielli   +6 more
wiley   +1 more source

Oral JAK Inhibitors as a Promising Therapeutic Strategy for Refractory Rosacea: A Systematic Review and Meta‐Analysis

open access: yesJournal of Cosmetic Dermatology, Volume 25, Issue 3, March 2026.
ABSTRACT Background Rosacea is a chronic inflammatory dermatosis. While standard therapies exist, managing refractory subtypes remains a therapeutic challenge. Oral Janus kinase (JAK) inhibitors have emerged as potential alternatives, but systematic evidence is lacking. Aims To evaluate the efficacy and safety of oral JAK inhibitors for rosacea through
Yu Peng   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy